Sign in
4

Changes in Ownership

PTC THERAPEUTICS, INC. Filed Acc 0001179110-20-010870

SVP, Finance & CAO sold 31,758 shares at an average $60.06 ($1,907,404)

  • SVP, Finance & CAO acquired 31,758 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Utter Christine Marie · SVP, Finance & CAO

Table I: Non-derivative

18 lines
Date Transaction Shares Price Value Owned after D/I
2020-11-04 Exercise or conversion : show line 1 in the form +1,567 $30.86 $48,358 11,129 D
2020-11-04 Sale : show line 2 in the form −1,567 $60.20 $94,333 9,562 D
2020-11-04 Exercise or conversion : show line 3 in the form +688 $30.86 $21,232 10,250 D
2020-11-04 Sale : show line 4 in the form −688 $60.00 $41,280 9,562 D
2020-11-04 Exercise or conversion : show line 5 in the form +355 $18.01 $6,394 9,917 D
2020-11-04 Sale : show line 6 in the form −355 $60.00 $21,300 9,562 D
2020-11-04 Exercise or conversion : show line 7 in the form +2,500 $18.01 $45,025 12,062 D
2020-11-04 Sale : show line 8 in the form −2,500 $60.00 $150,000 9,562 D
Open-market sales · 31,758 sh · avg $60.06 · $1,907,404

Table II: Derivative

9 lines
Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
2020-11-04 Exercise or conversion : show line 19 in the form Stock Option (Right To Buy) −1,567 $30.86 $48,358 $30.86 2026-01-03 1,567 8,743 D
2020-11-04 Exercise or conversion : show line 20 in the form Stock Option (Right to Buy) −688 $30.86 $21,232 $30.86 2026-01-03 688 8,055 D
2020-11-04 Exercise or conversion : show line 21 in the form Stock Option (Right to Buy) −355 $18.01 $6,394 $18.01 2028-01-02 355 15,000 D
2020-11-04 Exercise or conversion : show line 22 in the form Stock Option (Right to Buy) −2,500 $18.01 $45,025 $18.01 2028-01-02 2,500 12,500 D
2020-11-04 Exercise or conversion : show line 23 in the form Stock Option (Right to Buy) −8,055 $30.86 $248,577 $30.86 2026-01-03 8,055 0 D
2020-11-04 Exercise or conversion : show line 24 in the form Stock Option (Right To Buy) −2,656 $33.02 $87,701 $33.02 2029-01-21 2,656 39,844 D
2020-11-04 Exercise or conversion : show line 25 in the form Stock Option (Right to Buy) −2,656 $33.02 $87,701 $33.02 2029-01-21 2,656 37,188 D
2020-11-04 Exercise or conversion : show line 26 in the form Stock Option (Right to Buy) −10,625 $33.02 $350,838 $33.02 2029-01-21 10,625 26,563 D
2020-11-04 Exercise or conversion : show line 27 in the form Stock Option (Right to Buy) −2,656 $33.02 $87,701 $33.02 2029-01-21 2,656 23,907 D
Loading xslF345X03/edgar.xml…